Tenderwize
Back to tender search

Open house drug discount agreements multienzyme (Lipase, Protease etc.), ATC A09AA02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Feb 03, 2028 · 535 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Multienzyme (Lipase, Protease etc.), ATC A09AA02

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

25 / 100

Risk factors

No guaranteed sales; actual revenue depends on prescription volumes and market penetration.

Monthly cut-off deadlines require careful timing; missing the 3rd may delay contract start by up to two months.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Mar 2028
  • Non-exclusive drug discount agreements for multienzyme products (ATC A09AA02) with AOK Bayern.
  • Open-house model: all eligible pharmaceutical companies may join on identical terms.
Show full summary

Open-house model for non-exclusive drug discount agreements (Rabattverträge) for multienzymes (Lipase, Protease etc.), ATC A09AA02, with AOK Bayern. The procedure is not a competitive tender but a continuous open-house where any eligible pharmaceutical company can enter identical, non-negotiable agreements. The contract term is from 1 April 2026 to 31 March 2028, with possible early termination if superseded by regular discount contracts. There is no estimated value, and no award criteria since all eligible participants are accepted. The key eligibility requirement is a signed declaration of reliability. Submissions can be in paper (two copies) or electronically with a qualified electronic signature.

Risks

No guaranteed sales; actual revenue depends on prescription volumes and market penetration.

Monthly cut-off deadlines require careful timing; missing the 3rd may delay contract start by up to two months.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible to participate.

Administrative

  • Signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
  • Contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be signed and submitted in duplicate (paper) or with qualified electronic signature.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug discount agreements multienzyme (Lipase, Protease etc.), ATC A09AA02

Non-exclusive discount agreements for pharmaceutical products containing multienzymes (Lipase, Protease etc.), ATC A09AA02. The agreement is open to all pharmaceutical companies meeting the eligibility criteria. Contracts start on the first of the month following complete submission, with a monthly cut-off on the 3rd. The latest joining date is 3 February 2028.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Mar 2026 - Mar 2028

Category

Pharmaceutical products

Deadline

Deadline Feb 03, 2028

Procurement Details

Publication date
15 Feb 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
107164-2026

Documents (2)

Similar tenders